Inactive Instrument

Medivation Inc Stock

Stocks

End-of-day quote Nasdaq
- ^USD	-

16-10-28	Eli Lilly and : Drugmaker Sanofi hungry for deals after earnings beat	RE
16-09-07	Exclusive - GW Pharmaceuticals hires investment bank following approaches: sources	RE

16-10-28	Eli Lilly and : Drugmaker Sanofi hungry for deals after earnings beat	RE
16-09-07	Exclusive - GW Pharmaceuticals hires investment bank following approaches: sources	RE
16-07-08	Abbott Laboratories : Medtech's 2016 stock surge confronts second-quarter test	RE
16-06-03	Medivation : Ex-Oppenheimer adviser arrested for trading on Pfizer employee's tips	RE
16-06-02	Medivation : sets eligibility date for shareholder consent on board revamp	RE
16-05-25	Lonza : Sanofi moves to oust Medivation board in $9.3 billion takeover fight	RE
16-05-25	Lonza : Sanofi moves to oust Medivation board in $9.3 billion takeover fight	RE
16-05-25	Exclusive: Sanofi to unveil challenge to Medivation's board - sources	RE
16-05-10	Astellas Pharma : Medivation succumbs to pressure to explore sale - sources	RE
16-05-09	Exclusive - Medivation succumbs to pressure to explore sale: sources	RE
16-05-05	Medivation : Sanofi ready to up offer for drugmaker Medivation, could oust board	RE
16-05-04	Medivation : Sanofi sees 'strong strategic' fit with U.S. Medivation	RE
16-05-03	Exclusive: Pfizer approaches Medivation about potential takeover - sources	RE

16-10-09	Medivation : New Data Presented at ESMO 2016 Further Demonstrates XTANDITM▼ (enzalutamide) Significantly Improves Time to PSA Progression in Advanced Prostate Cancer, Compared with Placebo	BU
16-09-09	Faruqi & Faruqi, LLP : Announces Filing of a Class Action Lawsuit Against Medivation, Inc.	PR
16-08-25	Brower Piven Commences An Investigation Into The Proposed Sale Of Medivation, Inc. And Encourages Shareholders To Contact The Firm For Additional Information	BU
16-08-25	Levi & Korsinsky, LLP Announces an Investigation Regarding Whether the Sale of Medivation, Inc. for $81.50 Per Share is Fair to Shareholders	BU
16-08-23	SHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Medivation, Inc. -MDVN	PR

16-10-28	Sanofi : relève ses prévisions pour 2016 et s'envole en Bourse
16-10-27	Sanofi : relève ses prévisions pour 2016 et veut céder ses activités génériques en Europe
16-10-09	Medivation : Neue, im Rahmen der ESMO 2016 präsentierte Ergebnisse belegen zusätzlich, dass XTANDITM▼ (Enzalutamid) die Zeit bis zur PSA-Progression bei fortgeschrittenem Prostatakarzinom im Vergleich zu Placebo signifikant verlängert
16-10-09	Medivation : De nouvelles données présentées au Congrès 2016 de l’ESMO démontrent une fois de plus que XTANDITM▼ (enzalutamide) améliore nettement, par rapport au placebo, le délai avant progression du PSA en cas de cancer de la prostate avancé
16-09-19	Sanofi : poursuit Merck en justice aux USA pour protéger les brevets de Lantus

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	-0.32%	-5.97%	+57.78%	+74.48%	70.65B
ARGENX SE	-1.99%	-13.92%	+3.01%	+51.60%	51.22B
LONZA GROUP AG	-1.32%	-1.70%	+6.99%	+35.47%	48.04B
IQVIA HOLDINGS INC.	-0.58%	+0.27%	+27.93%	+30.76%	43.16B
REVOLUTION MEDICINES, INC.	-2.84%	-5.72%	+286.54%	+530.02%	41.57B
BEONE MEDICINES AG	-0.38%	-3.78%	+6.74%	+95.25%	39.84B
CELLTRION, INC.	-0.39%	-1.48%	+10.41%	+43.19%	30.87B
WUXI BIOLOGICS (CAYMAN) INC.	-2.66%	-11.49%	+42.12%	+4.38%	27.53B
BIONTECH SE	-7.13%	-7.02%	-12.99%	-14.07%	24.08B
Average	-1.96%	-4.77%	+47.61%	+94.56%	41.88B
Weighted average by Cap.	-1.60%	-4.99%	+50.74%	+100.49%